Altre lingue Stevia Corp.

Azioni

STEV

US86031P1066

Mercato chiuso - OTC Markets Altri mercati azionari 21:25:10 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,0026 ^USD	-2,99%		-21,21%	+30,00%

2022

Stevia Corp. annuncia la nomina di David L. Cooper nel suo gruppo di consulenza scientifica

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BigTime Penny Stocks: Weekly Watchlist (MGRX, PWDY, STEV, BDPT)	13/06/23
Stevia : Announces Appointment of the Former Chief Science Officer for Quest Diagnostics to its Scientific Advisory Panel	14/06/22
Stevia Corp. Announces Appointment of David L. Cooper to Its Scientific Advisory Panel	14/06/22
Stevia : Announces Real Hemp LLC's Collaboration With Internationally Recognized Designer and the Rubber Killer(R) Brand	21/10/15
Stevia : Reports on Budget Hemp's Better Than Expected Sales Numbers Following Launch of Online Store	15/09/15
Stevia : Reports on Initial Sales Trends for Realhemp(TM) Branded Product Lines	10/09/15
Stevia : Launches Its Bulk Hemp Products Online Store at www.BudgetHemp.com for Commercial Buyers	06/08/15
Stevia : Launches Its Online Store at www.RealhempStore.com Featuring Realhemp(TM) Branded Food and Skincare Product Lines	03/08/15
Stevia : Provides Update on 10-K Filing	03/08/15
Stevia : Discusses Partnership Plans While Continuing to Implement a Broad Intellectual Property and Commercial Strategy Related to Cannabis and Industrial Hemp	21/05/15
Stevia : Names Famed Cannabis Researcher and Former Indiana University Professor Paul Mahlberg to Its Advisory Panel	28/04/15
Stevia : Welcomes Biochemist and Former MD Anderson Cancer Researcher Dennis Hill to Its Newly Formed Advisory Panel	20/04/15
Stevia : on Track for Another Record Harvest	15/04/15
Stevia : Files Provisional Patent With the United States Patent and Trademark Office for a Non-Invasive and Simple to Use Delivery System for Cannabinoids	06/03/15
Stevia : Files Two Additional Provisional Patent Applications With the United States Patent and Trademark Office for a Cannabidiol (CBD) and Aspirin Formulation and a Cannabidiol and Naproxen Formulation to Treat Pain and Cardiovascular Disease	29/01/15
Stevia Corp. Files Two Additional Provisional Patent Applications with the United States Patent and Trademark Office for the Treatment of Pain and Cardiovascular Disease	29/01/15
Stevia : Provides Spring Harvest Guidance	28/01/15
Stevia : Announces Investor Update Conference Call	26/01/15
Stevia Corp. cancelled the transaction announced on January 26, 2012	26/01/15
Stevia Corp. Files Second Key Provisional Patent Application with the United States Patent and Trademark Office for a Cannabidiol and Ibuprofen Formulation to Treat Pain	20/01/15

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Stevia Corp.

Azioni

STEV

US86031P1066

Altre lingue

Filtri